# indie Semiconductor, Inc.: overview

INDI · Nasdaq · CIK 1841925 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/indi.md) · [Financials](/companies/indi/financials.md) · [Filings](/companies/indi/filings.md) · [Insiders](/companies/indi/insiders.md)

Latest reported revenue: [$64.0m](/filings/0001193125-26-340396.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-340396).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [54.0](/filings/0001193125-25-272468.md) | [58.0 d](/filings/0001193125-26-082535.md) | [54.1](/filings/0001193125-26-215104.md) | [51.6](/filings/0001193125-26-340396.md) | [53.7](/filings/0001193125-25-272468.md) | [58.0 d](/filings/0001193125-26-082535.md) | [55.5](/filings/0001193125-26-215104.md) | [64.0](/filings/0001193125-26-340396.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(92.5%)](/filings/0001193125-25-272468.md) | [(58.4%) d](/filings/0001193125-26-082535.md) | [(72.0%)](/filings/0001193125-26-215104.md) | [(83.3%)](/filings/0001193125-26-340396.md) | [(71.4%)](/filings/0001193125-25-272468.md) | [(58.5%) d](/filings/0001193125-26-082535.md) | [(70.1%)](/filings/0001193125-26-215104.md) | [(54.8%)](/filings/0001193125-26-340396.md) |
| Net margin | % | [(92.1%)](/filings/0001193125-25-272468.md) | [(56.2%) d](/filings/0001193125-26-082535.md) | [(63.9%)](/filings/0001193125-26-215104.md) | [(75.6%)](/filings/0001193125-26-340396.md) | [(71.3%)](/filings/0001193125-25-272468.md) | [(53.8%) d](/filings/0001193125-26-082535.md) | [(77.9%)](/filings/0001193125-26-215104.md) | [(57.9%)](/filings/0001193125-26-340396.md) |
| Diluted EPS | $ per share | [(0.28)](/filings/0001193125-25-272468.md) | not reported | [(0.18)](/filings/0001193125-26-215104.md) | [(0.20)](/filings/0001193125-26-340396.md) | [(0.19)](/filings/0001193125-25-272468.md) | not reported | [(0.21)](/filings/0001193125-26-215104.md) | [(0.17)](/filings/0001193125-26-340396.md) |
| Free cash flow | $m | [(29.3) d](/filings/0001193125-25-272468.md) | [(8.6) d](/filings/0001193125-26-082535.md) | [(31.4)](/filings/0001193125-26-215104.md) | [(13.6) d](/filings/0001193125-26-340396.md) | [(10.3) d](/filings/0001193125-25-272468.md) | [(16.1) d](/filings/0001193125-26-082535.md) | [(25.3)](/filings/0001193125-26-215104.md) | [(32.0) d](/filings/0001193125-26-340396.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [48.4](/filings/0001628280-24-008027.md) | [111](/filings/0001628280-25-009207.md) | [223](/filings/0001193125-26-082535.md) | [217](/filings/0001193125-26-082535.md) | [217](/filings/0001193125-26-082535.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [(154.5%)](/filings/0001628280-24-008027.md) | [(107.5%)](/filings/0001628280-25-009207.md) | [(60.7%)](/filings/0001193125-26-082535.md) | [(78.5%)](/filings/0001193125-26-082535.md) | [(70.9%)](/filings/0001193125-26-082535.md) |
| Net margin | % | [(181.9%)](/filings/0001628280-24-008027.md) | [(39.2%)](/filings/0001628280-25-009207.md) | [(52.7%)](/filings/0001193125-26-082535.md) | [(61.2%)](/filings/0001193125-26-082535.md) | [(65.8%)](/filings/0001193125-26-082535.md) |
| Diluted EPS | $ per share | [(1.26)](/filings/0001628280-24-008027.md) | [(0.37)](/filings/0001628280-25-009207.md) | [(0.81)](/filings/0001193125-26-082535.md) | [(0.76)](/filings/0001193125-26-082535.md) | [(0.73)](/filings/0001193125-26-082535.md) |
| Free cash flow | $m | [(58.5)](/filings/0001628280-24-008027.md) | [(84.3)](/filings/0001628280-25-009207.md) | [(117)](/filings/0001193125-26-082535.md) | [(72.9)](/filings/0001193125-26-082535.md) | [(71.4)](/filings/0001193125-26-082535.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/indi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [PRIMECAP MANAGEMENT CO/CA/](/funds/763212.md) | 2026-06-30 | $142.0m | 31,623,647 |  | Added +557,341 |
| [BAMCO INC /NY/](/funds/1017918.md) | 2026-06-30 | $103.3m | 23,012,611 |  | Reduced −325,215 |
| [Granahan Investment Management, LLC](/funds/1026710.md) | 2026-06-30 | $87.2m | 19,419,892 |  | Reduced −863,947 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $85.5m | 19,045,966 |  | Added +2,848,975 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $83.1m | 18,502,581 |  | Added +6,486,882 |
| [FRONTIER CAPITAL MANAGEMENT CO LLC](/funds/351173.md) | 2026-06-30 | $71.5m | 15,914,169 |  | Reduced −3,331,919 |
| [Elemental Capital Partners LLC](/funds/1860672.md) | 2026-06-30 | $59.8m | 13,309,443 |  | Added +665,050 |
| [NEUBERGER BERMAN GROUP LLC](/funds/1465109.md) | 2026-06-30 | $46.0m | 10,354,827 |  | Reduced −188,496 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $37.1m | 8,262,498 |  | Added +334,292 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $28.6m | 6,369,408 |  | Added +411,783 |

## Recent filings

[All 692 filings](/companies/indi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-07 | 16:58 ET | [8-K/A](/filings/0001193125-26-340444.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-340444 |
| 2026-08-07 | 16:40 ET | [10-Q](/filings/0001193125-26-340396.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340396 |
| 2026-08-06 | 16:33 ET | [8-K](/filings/0001193125-26-338258.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-338258 |
| 2026-06-22 | 16:16 ET | [8-K](/filings/0001193125-26-277534.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-277534 |
| 2026-05-29 | 16:21 ET | [8-K](/filings/0001193125-26-248380.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-248380 |
| 2026-05-11 | 16:35 ET | [8-K](/filings/0001193125-26-216934.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-216934 |
| 2026-05-11 | 17:35 ET | [10-Q](/filings/0001193125-26-215104.md) | Quarterly report, period 2026-03-31 | 0001193125-26-215104 |
| 2026-05-07 | 16:36 ET | [8-K](/filings/0001193125-26-212163.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-212163 |
| 2026-04-17 | 16:33 ET | [DEF 14A](/filings/0001193125-26-161644.md) | Proxy statement, period 2026-04-17 | 0001193125-26-161644 |
| 2026-03-18 | 17:17 ET | [8-K](/filings/0001213900-26-030936.md) | 8.01 Other events | 0001213900-26-030936 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-082535.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/67a58ca8-726e-4ff6-a852-f3bcccee106b)

## About the filer

- CIK: 1841925
- Tickers: INDI
- Exchange: Nasdaq
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 12:04 ET. No prices; not investment advice.